Article
Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC.
Scientific reports - 3 Jan 2024
Lu Jiameng, Ji Xiaoqing, Liu Xinyi, Jiang Yunxiu, Li Gang, Fang Ping, Li Wei, Zuo Anli, Guo Zihan, Yang Shuran, Ji Yanbo, Lu Degan
Abstract excerpt
The epidermal growth factor receptor (EGFR) Thr790 Met (T790M) mutation is responsible for approximately half of the acquired resistance to EGFR-tyrosine kinase inhibitor (TKI) in non-small-cell lung cancer (NSCLC) patients. Identifying patients at diagnosis who are likely to develop this mutation after first- or second-generation EGFR-TKI treatment is crucial for better treatment outcomes. This study aims to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
